[Preventive systemic antibiotherapy with ceftriaxone alone in neutropenic patients treated in a protected environment].

Author: BourhisJ H, CourtieuA L, DerriennicM, HarousseauJ L, MilpiedN, ReynaudA E

Paper Details 
Original Abstract of the Article :
Prophylactic systemic antibiotic therapy with ceftriaxone alone was tested in aplastic patients receiving total gut decontamination and treated in a protected environment. Only patients who were afebrile when their polymorphonuclear (PMN) count fell below 500/cumm were admitted to the study. Seventy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2962087

データ提供:米国国立医学図書館(NLM)

Preventing Infections in Neutropenic Patients: A Strategic Approach

Neutropenia, a condition characterized by low levels of white blood cells, leaves patients highly susceptible to infections. This research explores the effectiveness of prophylactic ceftriaxone therapy in preventing bacterial infections in neutropenic patients receiving treatment in a protected environment. Imagine this research as a fort in the desert, strategically protecting its inhabitants from the dangers lurking outside its walls.

Prophylactic Ceftriaxone: A Protective Shield

The study demonstrated that prophylactic ceftriaxone significantly reduced the incidence of fever, bacteremia, and overall infections in neutropenic patients treated in a protected environment. These findings suggest that prophylactic antibiotic therapy can effectively prevent infections in this vulnerable population.

A Vital Strategy for Infection Prevention

This research underscores the importance of proactive strategies for preventing infections in neutropenic patients. Prophylactic ceftriaxone therapy can be a valuable tool in the fight against infections, providing a vital shield against the dangers of neutropenia. Just like a desert fortress protects its inhabitants, this therapy can help protect vulnerable patients from the threats of infection.

Dr.Camel's Conclusion

This research highlights the effectiveness of prophylactic ceftriaxone therapy in preventing infections in neutropenic patients treated in a protected environment. These findings underscore the importance of proactive strategies for protecting vulnerable individuals from the dangers of infection, much like a well-fortified oasis provides safety from the harsh desert environment.

Date :
  1. Date Completed 1988-01-25
  2. Date Revised 2016-12-09
Further Info :

Pubmed ID

2962087

DOI: Digital Object Identifier

2962087

Related Literature

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.